Enhanced Drug Distribution Security: 2023 and Beyond
Starts On:
Fri, 2/25/22: 12:00 AM EST
Ends On:
Tue, 12/31/24: 12:00 AM EST
Type:
Enduring Material
Credits:
1
Description:
FDA will provide updates on implementation of supply chain security requirements under the Drug Supply Chain Security Act and describe requirements that go into effect in 2023 for enhanced drug distribution security. Enhanced product tracing and verification will help protect patients by improving detection and response to suspect and illegitimate products and prevent the distribution of illegitimate products in the U.S. FDA and the supply chain will need to work together to establish a fully electronic, interoperable system for enhanced drug distribution security across the entire drug supply chain.
Objectives:
- Summarize updates on implementation of supply chain security requirements under the Drug Supply Chain
Security Act (DSCSA). - Describe requirements that go into effect in 2023 for enhanced drug distribution security.
- Explain how enhanced drug distribution security will help protect patients from exposure to drugs that may be
counterfeit, stolen, contaminated, or otherwise harmful.
Additional Information:
Review the Activity Announcement for additional details: Announcement Form
Additional Resources: Slides
Additional Resources: Slides